Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid…

Overview of attention for article published in BMC Health Services Research, May 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

So far, Altmetric has seen 2 news stories from 1 outlets.

A combination of methotrexate with either biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDS (ts…

Juthamas Prawjaeng, Pharm D Credit: LinkedIn New data found despite the effective reduction in disease activity and an…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.